Mayukh Sukhatme - 25 Jun 2026 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Reporting relationship: President & CIO, Director
Issuer ticker: ROIV
Reported as of: 25 Jun 2026
Net transaction value: -$34,105,000
SEC form: 4
Accepted by SEC: 29 Jun 2026, 18:23:06 UTC
Prior SEC filing: 01 Apr 2026
Next SEC filing: 02 Jul 2026
Source filing: View source filing
Reporting owner signature: By: /s/ Jo Chen, as Attorney-in-Fact for Mayukh Sukhatme

Key filing fact

Mayukh Sukhatme filed Form 4 for Roivant Sciences Ltd. (ROIV) on 29 Jun 2026.

Key facts

This page summarizes Mayukh Sukhatme's Form 4 filing for Roivant Sciences Ltd. (ROIV).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 29 Jun 2026, 18:23.

Change

Previous filing in this sequence was filed on 01 Apr 2026.
Current net transaction value: -$34,105,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001750050 Primary reporting owner

Sukhatme Mayukh

Relationship: President & CIO, Director
Address: C/O ROIVANT SCIENCES LTD., 7TH FLOOR, 50 BROADWAY, LONDON, UNITED KINGDOM
Signature: By: /s/ Jo Chen, as Attorney-in-Fact for Mayukh Sukhatme
Signature date: 29 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ROIV transaction

Common Shares

Options Exercise

Transaction value
Shares: +500,000
Change %: +2.7%
Price: $3.85^*
Shares after: 19,177,617
Date: 25 Jun 2026
Ownership: Direct

ROIV transaction

Common Shares

Sale

Transaction value: $17,065,000
Shares: -500,000
Change %: -2.6%
Price: $34.13
Shares after: 18,677,617
Date: 25 Jun 2026
Ownership: Direct
Footnotes: F1

ROIV transaction

Common Shares

Options Exercise

Transaction value
Shares: +500,000
Change %: +2.7%
Price: $3.85^*
Shares after: 19,177,617
Date: 26 Jun 2026
Ownership: Direct

ROIV transaction

Common Shares

Sale

Transaction value: $17,040,000
Shares: -500,000
Change %: -2.6%
Price: $34.08
Shares after: 18,677,617
Date: 26 Jun 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ROIV transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -500,000
Change %: -3.3%
Price: $0.000000^*
Shares after: 14,724,363
Date: 25 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 500,000
Exercise price: $3.85
Footnotes: F3

ROIV transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -500,000
Change %: -3.4%
Price: $0.000000^*
Shares after: 14,224,363
Date: 26 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 500,000
Exercise price: $3.85
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.87 to $34.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

Footnote F2

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.75 to $34.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

Footnote F3

Award of stock options to purchase Common Shares that is fully vested.